↓ Skip to main content

Gliomas and the vascular fragility of the blood brain barrier

Overview of attention for article published in Frontiers in Cellular Neuroscience, December 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

twitter
3 X users

Citations

dimensions_citation
241 Dimensions

Readers on

mendeley
355 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Gliomas and the vascular fragility of the blood brain barrier
Published in
Frontiers in Cellular Neuroscience, December 2014
DOI 10.3389/fncel.2014.00418
Pubmed ID
Authors

Luiz Gustavo Dubois, Loraine Campanati, Cassia Righy, Isabella D’Andrea-Meira, Tania Cristina Leite de Sampaio e Spohr, Isabel Porto-Carreiro, Claudia Maria Pereira, Joana Balça-Silva, Suzana Assad Kahn, Marcos F. DosSantos, Marcela de Almeida Rabello Oliveira, Adriana Ximenes-da-Silva, Maria Celeste Lopes, Eduardo Faveret, Emerson Leandro Gasparetto, Vivaldo Moura-Neto

Abstract

Astrocytes, members of the glial family, interact through the exchange of soluble factors or by directly contacting neurons and other brain cells, such as microglia and endothelial cells. Astrocytic projections interact with vessels and act as additional elements of the Blood Brain Barrier (BBB). By mechanisms not fully understood, astrocytes can undergo oncogenic transformation and give rise to gliomas. The tumors take advantage of the BBB to ensure survival and continuous growth. A glioma can develop into a very aggressive tumor, the glioblastoma (GBM), characterized by a highly heterogeneous cell population (including tumor stem cells), extensive proliferation and migration. Nevertheless, gliomas can also give rise to slow growing tumors and in both cases, the afflux of blood, via BBB is crucial. Glioma cells migrate to different regions of the brain guided by the extension of blood vessels, colonizing the healthy adjacent tissue. In the clinical context, GBM can lead to tumor-derived seizures, which represent a challenge to patients and clinicians, since drugs used for its treatment must be able to cross the BBB. Uncontrolled and fast growth also leads to the disruption of the chimeric and fragile vessels in the tumor mass resulting in peritumoral edema. Although hormonal therapy is currently used to control the edema, it is not always efficient. In this review we comment the points cited above, considering the importance of the BBB and the concerns that arise when this barrier is affected.

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 355 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 <1%
United Kingdom 1 <1%
Netherlands 1 <1%
Denmark 1 <1%
Canada 1 <1%
Unknown 349 98%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 66 19%
Researcher 51 14%
Student > Master 50 14%
Student > Bachelor 37 10%
Student > Doctoral Student 23 6%
Other 61 17%
Unknown 67 19%
Readers by discipline Count As %
Medicine and Dentistry 70 20%
Agricultural and Biological Sciences 51 14%
Neuroscience 43 12%
Biochemistry, Genetics and Molecular Biology 40 11%
Pharmacology, Toxicology and Pharmaceutical Science 15 4%
Other 55 15%
Unknown 81 23%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 April 2018.
All research outputs
#15,835,490
of 25,067,172 outputs
Outputs from Frontiers in Cellular Neuroscience
#2,445
of 4,644 outputs
Outputs of similar age
#202,420
of 368,812 outputs
Outputs of similar age from Frontiers in Cellular Neuroscience
#38
of 85 outputs
Altmetric has tracked 25,067,172 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 4,644 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.7. This one is in the 44th percentile – i.e., 44% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,812 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 42nd percentile – i.e., 42% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 85 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.